Clinical and psychosocial factors predicting persistent smoking in hospitalized patients with atherosclerotic vascular disease: A prespecified analysis of two randomized controlled trials.

IF 2.3 Q3 SUBSTANCE ABUSE
Tobacco Prevention & Cessation Pub Date : 2026-03-13 eCollection Date: 2026-01-01 DOI:10.18332/tpc/217328
Vilde Getz, Karin Pleym, Toril Dammen, Einar Husebye, Elise Sverre, Costas Papageorgiou, Harald Weedon-Fekjær, John Munkhaugen
{"title":"Clinical and psychosocial factors predicting persistent smoking in hospitalized patients with atherosclerotic vascular disease: A prespecified analysis of two randomized controlled trials.","authors":"Vilde Getz, Karin Pleym, Toril Dammen, Einar Husebye, Elise Sverre, Costas Papageorgiou, Harald Weedon-Fekjær, John Munkhaugen","doi":"10.18332/tpc/217328","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Smoking remains prevalent after hospitalization for atherosclerotic vascular disease, even with cessation programs. Understanding the clinical and psychosocial factors influencing long-term abstinence is essential for identifying patients who may benefit from tailored interventions. This study aimed to identify clinical and psychosocial factors associated with sustained smoking cessation in patients with atherosclerotic disease who were admitted to hospital for an elective or unplanned vascular event and enrolled in a cessation intervention study.</p><p><strong>Methods: </strong>This is a prespecified analysis of two randomized intervention trials that recruited participants from three secondary care hospitals in Norway between 2021 and 2023. Patients who smoked at least one cigarette daily before admission were randomized to: 1) motivational counselling and proactive referral to municipal cessation services (intervention); or 2) brief advice and contact information (control). Data were collected from medical records, a questionnaire, and telephone interviews. Logistic regression analyses were used to identify the prespecified factors associated with smoking status at 12 months.</p><p><strong>Results: </strong>In the total study population (n=262), 34% (n=88) reported 12-month sustained smoking abstinence. Anxiety diagnosis (adjusted odds ratio, AOR=4.2), shorter sleep duration per hour (AOR=1.3), living alone (AOR=2.2), somatic comorbidity per point on the Charlson score (AOR=1.5), and being in the precontemplation stage (AOR=2.9) were associated with persistent smoking. Increasing motivation per point on a 0-10 Likert scale (AOR=0.7), being in the preparation stage (AOR=0.4), and myocardial infarction or stroke as the index diagnosis (AOR=0.5) were associated with smoking abstinence. Results were generally consistent across intervention allocation groups.</p><p><strong>Conclusions: </strong>Motivation and readiness for smoking cessation were key predictors of abstinence. Living alone, anxiety disorders, and shorter sleep duration were associated with persistent smoking. These factors may help identify subgroups who could benefit from more targeted support.</p><p><strong>Clinical trial registration: </strong>The study is registered on the official website of ClinicalTrials.gov.</p><p><strong>Identifiers: </strong>NCT04772144 and NCT05049174.</p>","PeriodicalId":44546,"journal":{"name":"Tobacco Prevention & Cessation","volume":"12 ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13001752/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tobacco Prevention & Cessation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18332/tpc/217328","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Smoking remains prevalent after hospitalization for atherosclerotic vascular disease, even with cessation programs. Understanding the clinical and psychosocial factors influencing long-term abstinence is essential for identifying patients who may benefit from tailored interventions. This study aimed to identify clinical and psychosocial factors associated with sustained smoking cessation in patients with atherosclerotic disease who were admitted to hospital for an elective or unplanned vascular event and enrolled in a cessation intervention study.

Methods: This is a prespecified analysis of two randomized intervention trials that recruited participants from three secondary care hospitals in Norway between 2021 and 2023. Patients who smoked at least one cigarette daily before admission were randomized to: 1) motivational counselling and proactive referral to municipal cessation services (intervention); or 2) brief advice and contact information (control). Data were collected from medical records, a questionnaire, and telephone interviews. Logistic regression analyses were used to identify the prespecified factors associated with smoking status at 12 months.

Results: In the total study population (n=262), 34% (n=88) reported 12-month sustained smoking abstinence. Anxiety diagnosis (adjusted odds ratio, AOR=4.2), shorter sleep duration per hour (AOR=1.3), living alone (AOR=2.2), somatic comorbidity per point on the Charlson score (AOR=1.5), and being in the precontemplation stage (AOR=2.9) were associated with persistent smoking. Increasing motivation per point on a 0-10 Likert scale (AOR=0.7), being in the preparation stage (AOR=0.4), and myocardial infarction or stroke as the index diagnosis (AOR=0.5) were associated with smoking abstinence. Results were generally consistent across intervention allocation groups.

Conclusions: Motivation and readiness for smoking cessation were key predictors of abstinence. Living alone, anxiety disorders, and shorter sleep duration were associated with persistent smoking. These factors may help identify subgroups who could benefit from more targeted support.

Clinical trial registration: The study is registered on the official website of ClinicalTrials.gov.

Identifiers: NCT04772144 and NCT05049174.

Abstract Image

预测动脉粥样硬化性血管疾病住院患者持续吸烟的临床和社会心理因素:两项随机对照试验的预先指定分析
导读:因动脉粥样硬化性血管疾病住院后,吸烟仍然普遍存在,即使有戒烟计划。了解影响长期禁欲的临床和社会心理因素对于确定可能从量身定制的干预措施中受益的患者至关重要。本研究旨在确定与动脉粥样硬化性疾病患者持续戒烟相关的临床和社会心理因素,这些患者因选择性或非计划的血管事件而入院,并参加了戒烟干预研究。方法:这是对两项随机干预试验的预先指定分析,这些试验在2021年至2023年间从挪威的三家二级护理医院招募参与者。入院前每天至少抽一支烟的患者被随机分配到:1)动机咨询和主动转介到市政戒烟服务(干预);或2)简短的建议和联系方式(控制)。数据收集自医疗记录、问卷调查和电话访谈。采用Logistic回归分析确定与12个月时吸烟状况相关的预设因素。结果:在总研究人群(n=262)中,34% (n=88)报告了12个月的持续戒烟。焦虑诊断(调整优势比,AOR=4.2)、每小时较短的睡眠时间(AOR=1.3)、独居(AOR=2.2)、Charlson评分每分的躯体共病(AOR=1.5)和处于沉思前阶段(AOR=2.9)与持续吸烟相关。在0-10李克特量表上每分增加动机(AOR=0.7),处于准备阶段(AOR=0.4),以及心肌梗死或中风作为指标诊断(AOR=0.5)与戒烟相关。各干预分配组的结果基本一致。结论:戒烟的动机和准备是戒烟的关键预测因素。独居、焦虑症和较短的睡眠时间与持续吸烟有关。这些因素可能有助于确定可以从更有针对性的支持中受益的亚群体。临床试验注册:本研究在clinicaltrials .gov.官网注册,注册编号:NCT04772144和NCT05049174。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.80
自引率
0.00%
发文量
155
审稿时长
4 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书